Arata Azuma (Luca Richeldi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Magnetic Nanoparticles

Idiopathic Pulmonary Fibrosis

Top Venues

ERJ open research

BMJ open respiratory research

Molecular genetics & genomic medicine

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Toby M Maher, Shervin Assassi, Arata Azuma, Vincent Cottin, Anna-Maria Hoffmann-Vold, Michael Kreuter, Justin M Oldham, Luca Richeldi, Claudia Valenzuela, Marlies S Wijsenbeek, Carl Coeck, Christina Schlecker, Florian Voss, Daniel Wachtlin, Fernando J Martinez
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD). BMJ open respiratory research 10 (1) (2023)
Takashi Ogura, Yoshikazu Inoue, Arata Azuma, Sakae Homma, Yasuhiro Kondoh, Katsumi Tanaka, Kaori Ochiai, Yukihiko Sugiyama, Toshihiro Nukiwa
Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan. Advances in therapy (2023)
Arata Azuma, Arata Azuma, Vincent Cottin, Michael Kreuter, Toby M Maher, Fernando J Martinez, Justin M Oldham, Claudia Valenzuela, Maud Gordat, Yi Liu, Susanne Stowasser, Donald F Zoz, Marlies S Wijsenbeek
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF). BMJ open respiratory research 10 (1) (2023)
Junko Terada-Hirashima, Shinyu Izumi, Daisuke Katagiri, Yukari Uemura, Ayako Mikami, Wataru Sugiura, Shinji Abe, Arata Azuma, Haruhito Sugiyama
Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study. JMIR research protocols 11 (11) (2022)
Yasuhiro Kondoh, Arata Azuma, Jun Tagawa, Sakae Homma
Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial. American journal of respiratory and critical care medicine 202 (1) (2020)
Yuji Minegishi, Akihiko Gemma, Sakae Homma, Kazuma Kishi, Arata Azuma, Takashi Ogura, Naoki Hamada, Hiroyuki Taniguchi, Noboru Hattori, Yasuhiko Nishioka, Kiminobu Tanizawa, Takeshi Johkoh, Takuma Yokoyama, Kazutaka Mori, Yoshio Taguchi, Masahito Ebina, Naohiko Inase, Koichi Hagiwara, Hiroshi Ohnishi, Hiroshi Mukae, Yoshikazu Inoue, Kazuyoshi Kuwano, Hirofumi Chiba, Ken Ohta, Yoshinori Tanino, Fumikazu Sakai, Yukihiko Sugiyama
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan. ERJ open research 6 (2) (2020)
Naoto Keicho, Minako Hijikata, Kozo Morimoto, Sakae Homma, Yoshio Taguchi, Arata Azuma, Shoji Kudoh
Primary ciliary dyskinesia caused by a large homozygous deletion including exons 1-4 of DRC1 in Japanese patients with recurrent sinopulmonary infection. Molecular genetics & genomic medicine 8 (1) (2019)
Vincent Cottin, Arata Azuma, Ganesh Raghu, Wibke Stansen, Susanne Stowasser, Rozsa Schlenker-Herceg, Martin R J Kolb
Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials. The European respiratory journal 53 (4) (2019)
Vincent Cottin, Dirk Koschel, Andreas Günther, Carlo Albera, Arata Azuma, C Magnus Sköld, Sara Tomassetti, Philip Hormel, John L Stauffer, Indiana Strombom, Klaus-Uwe Kirchgaessler, Toby M Maher
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study. ERJ open research 4 (4) (2018)